| ORUKA THERAPEUTICS INC. |
| USA |
| Gesundheit |
| US6876041087 / A3DPH3 |
| HQ1 (Frankfurt) / ORKA (NASDAQ) |
| FRA:HQ1, ETR:HQ1, HQ1:GR, NASDAQ:ORKA |
| - |
| https://orukatx.com/ |
|
Oruka Therapeutics, Inc. is a clinical-stage biote..
>Volltext.. |
| 1194.17 Mio. EUR |
| 900.4 Mio. EUR |
| - |
| -100.47 Mio. EUR |
| -86.63 Mio. EUR |
| -2.06 EUR |
| 1.63 Mio. EUR |
| 77.78 Mio. EUR |
| -71.97 Mio. EUR |
| 16.65 |
| - |
| -180.33% |
| - |
| - |
| - |
| - |
| ORUKA |
| 18.12.25 |
|
||||
|